Cargando…
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study
Erythroferrone (ERFE) is a hepcidin inhibitor whose synthesis is stimulated by erythropoietin, which increases iron absorption and mobilization. We studied the association between serum ERFE and mortality and non-fatal cardiovascular (CV) events in a cohort of 1123 hemodialysis patients and in a coh...
Autores principales: | Spoto, Belinda, Kakkar, Rahul, Lo, Larry, Devalaraja, Matt, Pizzini, Patrizia, Torino, Claudia, Leonardis, Daniela, Cutrupi, Sebastiano, Tripepi, Giovanni, Mallamaci, Francesca, Zoccali, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518296/ https://www.ncbi.nlm.nih.gov/pubmed/30995819 http://dx.doi.org/10.3390/jcm8040523 |
Ejemplares similares
-
Vitamin D and methylarginines in chronic kidney disease (CKD)
por: Torino, Claudia, et al.
Publicado: (2017) -
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
por: Torino, Claudia, et al.
Publicado: (2018) -
Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients
por: Torino, Claudia, et al.
Publicado: (2017) -
Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model
por: D'Arrigo, Graziella, et al.
Publicado: (2023) -
Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients?
por: Provenzano, Pasquale Fabio, et al.
Publicado: (2023)